Publications by the researcher in collaboration with ANA MARIA MUÑOZ PATIÑO (12)

2010

  1. Nigral and striatal regulation of angiotensin receptor expression by dopamine and angiotensin in rodents: Implications for progression of Parkinson's disease

    European Journal of Neuroscience, Vol. 32, Núm. 10, pp. 1695-1706

2008

  1. Brain angiotensin enhances dopaminergic cell death via microglial activation and NADPH-derived ROS

    Neurobiology of Disease, Vol. 31, Núm. 1, pp. 58-73

2007

  1. Mechanism of 6-hydroxydopamine neurotoxicity: The role of NADPH oxidase and microglial activation in 6-hydroxydopamine-induced degeneration of dopaminergic neurons

    Journal of Neurochemistry, Vol. 103, Núm. 1, pp. 145-156

  2. Serotonin decreases generation of dopaminergic neurons from mesencephalic precursors via serotonin type 7 and type 4 receptors

    Developmental Neurobiology, Vol. 67, Núm. 1, pp. 10-22

2006

  1. Reduction of dopaminergic degeneration and oxidative stress by inhibition of angiotensin converting enzyme in a MPTP model of parkinsonism

    Neuropharmacology, Vol. 51, Núm. 1, pp. 112-120

2005

  1. Glial overexpression of heme oxygenase-1: A histochemical marker for early stages of striatal damage

    Journal of Chemical Neuroanatomy, Vol. 29, Núm. 2, pp. 113-126

2004

  1. Systemic Administration of N-Acetylcysteine Protects Dopaminergic Neurons Against 6-Hydroxydopamine-Induced Degeneration

    Journal of Neuroscience Research, Vol. 76, Núm. 4, pp. 551-562

2003

  1. Host brain regulation of dopaminergic grafts function: Role of the serotonergic and noradrenergic systems in amphetamine-induced responses

    Synapse, Vol. 47, Núm. 1, pp. 66-76

  2. Interaction between the noradrenergic and serotonergic systems in locomotor hyperactivity and striatal expression of Fos induced by amphetamine in rats

    Experimental Brain Research, Vol. 153, Núm. 1, pp. 92-99

2001

  1. Long-term cortical atrophy after excitotoxic striatal lesion: Effects of intrastriatal fetal-striatum grafts and implications for Huntington disease

    Journal of Neuropathology and Experimental Neurology, Vol. 60, Núm. 8, pp. 786-797

2000

  1. Fenfluramine-induced increase in preproenkephalin mRNA levels in the striatum: Interaction between the serotonergic, glutamatergic, and dopaminergic systems

    Synapse, Vol. 35, Núm. 3, pp. 182-191

  2. GABA(A) receptor subunit expression in intrastriatal ventral mesencephalic transplants

    Experimental Brain Research, Vol. 135, Núm. 3, pp. 331-340